[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363057-105":59,"doc-detail-363057-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","arhgap44-gene-a-cytoskeleton-mobility-related-modulator-with-implications-in-pan-cancer-prognostic-risk-and-immune-regulation","ARHGAP44 gene - a cytoskeleton mobility-related modulator with implications in pan-cancer prognostic risk and immune regulation","","Rho GTPases regulate cytoskeleton dynamics and multiple stages of cancer progression, yet the role of ARHGAP44, a GAP family member controlling Rho GTPase cycling between active GTP- and inactive GDP-bound states, remains insufficiently characterized. This study analyzes ARHGAP44 across a broad spectrum of human cancers by profiling genetic characteristics, expression patterns, frequent alterations, survival prediction value, and links to cancer clinical parameters, immune infiltration, and drug sensitivity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/arhgap44-gene-a-cytoskeleton-mobility-related-modulator-with-implications-in-pan-cancer-prognostic-risk-and-immune-regulation/363057/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/arhgap44-gene-a-cytoskeleton-mobility-related-modulator-with-implications-in-pan-cancer-prognostic-risk-and-immune-regulation/363057.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is ARHGAP44, and why is it important in cancer research?","Question",{"text":113,"@type":114},"ARHGAP44 is a GAP protein member involved in regulating Rho GTPase cycling between active and inactive states, which ties it to cytoskeleton dynamics. Its contribution to cancer development and progression remains insufficiently understood, motivating this study.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the study evaluate ARHGAP44 across cancers?",{"text":118,"@type":114},"The analysis covers genetic characteristics, expression patterns, frequent alterations, and survival prediction value across diverse human cancers. It also investigates reasons for aberrant expression, correlations with key clinical parameters, and links to immune infiltration and cancer traits.",{"name":120,"@type":111,"acceptedAnswer":121},"What associations are reported for ARHGAP44 regarding prognosis, immunity, and treatment?",{"text":122,"@type":114},"ARHGAP44 is associated with pan-cancer prognostic risk and immune regulation, including immune infiltration and cancer traits such as stemness and cytoskeleton dynamics. The results also indicate associations with the sensitivity of several chemotherapy-related drugs.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363057,1790445861,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 31 March 2026  \nDOI 10.3389/fonc.2026.1721943  \nOPEN ACCESS  \nEDITED BY  \nPrashanth N. Suravajhala,  \nManipal University Jaipur, India  \nREVIEWED BY  \nYi-Ting Huang,  \nNational Institutes of Health (NIH), United States  \nAditi Kaloni,  \nGujarat Technological University, India  \n*CORRESPONDENCE  \nWenxia Ma  \n [mawenxia@sxmu.edu.cn](mawenxia@sxmu.edu.cn)[ ](mawenxia@sxmu.edu.cn)Chen Wang  \n[wangchen@sxmu.edu.cn](wangchen@sxmu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 10 October 2025  \nREVISED 28 February 2026  \nACCEPTED 03 March 2026  \nPUBLISHED 31 March 2026  \nCITATION  \nMa W, Li J, Yang H, Wang X, Liu S, Miao L, Shen N, Yang Z, Gao L and Wang C (2026) ARHGAP44 gene: a cytoskeleton mobility-related modulator with implications in pan-cancer prognostic risk and immune regulation. Front. Oncol. 16:1721943 .  \ndoi: 10.3389/fonc.2026.1721943  \nCOPYRIGHT  \n© 2026 Ma, Li, Yang, Wang, Liu, Miao, Shen, Yang, Gao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nARHGAP44 gene: a cytoskeleton mobility-related modulator with implications in pan-cancer prognostic risk and immune regulation  \nWenxia Ma 1,2*†, Jiayao Li 2†, Huijun Yang 2, Xuzhi Wang 2, Siying Liu 2,3, Lei Miao 4, Ningning Shen 1, Zhiqing Yang 1, Lifang Gao 1 and Chen Wang 1*  \n1 Department of Pathology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China,  \n2 Department of Pathology, Second Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, China, 3 Department of Pathology, Public Health School of Shanxi Medical University, Taiyuan, Shanxi, China, 4 Department of Pathology, Basical College of Shanxi Medical University, Taiyuan, Shanxi, China  \nIntroduction: Rho GTPases have been a well-known family of small G proteins that regulate cellular cytoskeleton dynamics and are involved in multiple critical steps of cancer progression. However, ARHGAP44 gene, a member of GAP proteins that regulate the Rho GTPases cycling between their active GTPbound and inactive GDP-bound states, remains poorly understood in terms of its role in cancer development. This study aims to analyze the functions of ARHGAP44 gene in a broad spectrum of human cancers, thus aiding in the better understanding of the collaborative network of cytoskeleton-related genes in cancers.  \nMethods: The study started with the analysis of the genetic characteristics of ARHGAP44 gene, followed by its expression patterns, frequent alterations as well as survival prediction value in a broad spectrum of human cancers. Furthermore, the probable reasons for the aberrant changed expression of ARHGAP44 in cancers compared to corresponding normal control samples were investigated. Moreover, the correlation of ARHGAP44 with multiple critical clinical cancer parameters was performed in succession.  \nResults: The basic genetic physicochemical properties of ARHGAP44 including its amino-acid composition, estimated molecular weight, and protein half-life were investigated. Then, genetic alteration analysis revealed that ARHGAP44 expression varies in human cancers, which was partly due to the modulation by DNA methylation and phosphorylation. Furthermore, ARHGAP44 gene was associated with multiple critical cancer traits including cancer stemness, cytoskeleton dynamics as well as immune inﬁltration in different human cancer  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \ntypes. Moreover, ARHGAP44 gene was also associated with the sensitivity of several chemotherapy-related drugs.  \nConclusions: Based on multiple anal","cbCainPLENXa5Qaq","https://ap.wps.com/l/cbCainPLENXa5Qaq","pdf",19234610,21,"English","# Introduction\n## Rho GTPases and cytoskeleton dynamics in cancer\n## ARHGAP44 knowledge gap and study aim\n# Methods\n## Genetic characteristics and expression profiling\n## Alterations, survival prediction, and clinical associations\n## Mechanisms of aberrant expression and parameter correlation\n# Results\n## Genetic and physicochemical properties\n## Expression variation, DNA methylation and phosphorylation\n## Associations with cancer traits and immune infiltration\n## Chemotherapy drug sensitivity links\n# Conclusions","[{\"question\":\"What is ARHGAP44, and why is it important in cancer research?\",\"answer\":\"ARHGAP44 is a GAP protein member involved in regulating Rho GTPase cycling between active and inactive states, which ties it to cytoskeleton dynamics. Its contribution to cancer development and progression remains insufficiently understood, motivating this study.\"},{\"question\":\"How does the study evaluate ARHGAP44 across cancers?\",\"answer\":\"The analysis covers genetic characteristics, expression patterns, frequent alterations, and survival prediction value across diverse human cancers. It also investigates reasons for aberrant expression, correlations with key clinical parameters, and links to immune infiltration and cancer traits.\"},{\"question\":\"What associations are reported for ARHGAP44 regarding prognosis, immunity, and treatment?\",\"answer\":\"ARHGAP44 is associated with pan-cancer prognostic risk and immune regulation, including immune infiltration and cancer traits such as stemness and cytoskeleton dynamics. The results also indicate associations with the sensitivity of several chemotherapy-related drugs.\"}]","ARHGAP44 gene - a cytoskeleton mobility-related modulator with implications in pan-cancer prognostic risk and immune regulation | PDF",1790149817,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a30ab81678427b395be6e9ac1f92f2c6.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef7770b3e496888c34245fe1486345f5.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4ea3769b68cb9e3976dd9c4ba0fd9fd.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec0181cd3087f1a8c86c323eee149488.webp",980,1385]